Doxazosin Tablet
Product Images NDC 50090-8055

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-8055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (C2bacf15 E521 4d06 B4c6 45b40036b73c 01)

Chemical structure diagram of the active ingredient doxazosin and its associated molecule, likely representing doxazosin mesylate.*

FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 02)

A data table and bar graph showing results from three clinical studies comparing symptom scores and maximum flow rate (mL/sec) for placebo and doxazosin treatments, including 4 mg and 8 mg doses. The table reports mean baseline values and mean changes, while the graph highlights maximum flow rate improvements and symptom score reductions for 4 mg and 8 mg doxazosin compared to placebo in Study 2.*

FDA Label Image

Image (C2bacf15 E521 4d06 B4c6 45b40036b73c 03)

Two line graphs comparing Doxazosin with placebo over treatment duration (up to 14 weeks). The left graph shows mean change in total symptom score from baseline, with Doxazosin decreasing more significantly. The right graph depicts mean increase in maximum urinary flow rate (mL/sec) from baseline, showing higher increases with Doxazosin. Data includes sample sizes (N=50 for Doxazosin, N=47 for placebo).*

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 04)

FDA Label Image

Logo (C2bacf15 E521 4d06 B4c6 45b40036b73c 05)

FDA Label Image

Label Image (Lbl500908055)

Doxazosin 4 mg oral tablets packaging label from A-S Medication Solutions. The label includes the NDC 50090-8055-0, lot number, and indicates each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin as a free base. Storage instructions specify keeping the product at 68 to 77 degrees Fahrenheit. The package contains 30 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.